Playback speed
10 seconds
ESMO 2024 Insights: VOLGA Trial - ctDNA Clearance in Cisplatin-Ineligible MIBC With Durvalumab + Tremelimumab + Enfortumab Vedotin
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Alexandra Drakaki
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Alexandra Drakaki
21 views
September 23, 2024
Login to view comments.
Click here to Login